Single nucleotide polymorphisms in TP53 but not KRAS or MDM2 are predictive of clinical outcome in multiple myeloma treated with high-dose melphalan and autologous stem cell support

Niklas Gebauer; Harald Biersack; Ann Cathrin Czerwinska; Janina Schemme; Tim Tristan Hardel; Veronica Bernard; Dirk Rades; Hendrik Lehnert; Kim Barbara Luley; Christoph Thorns

doi:10.3109/10428194.2015.1099648

Single nucleotide polymorphisms in TP53 but not KRAS or MDM2 are predictive of clinical outcome in multiple myeloma treated with high-dose melphalan and autologous stem cell support

Niklas Gebauer^*, Harald Biersack, Ann Cathrin Czerwinska, Janina Schemme, Tim Tristan Hardel, Veronica Bernard, Dirk Rades, Hendrik Lehnert, Kim Barbara Luley, Christoph Thorns

^*Korrespondierende/r Autor/-in für diese Arbeit

3 Zitate (Scopus)

Originalsprache	Englisch
Zeitschrift	Leukemia and Lymphoma
Jahrgang	57
Ausgabenummer	6
Seiten (von - bis)	1482-1486
Seitenumfang	5
ISSN	1042-8194
DOIs	https://doi.org/10.3109/10428194.2015.1099648
Publikationsstatus	Veröffentlicht - 02.06.2016

UN SDGs

Dieser Output leistet einen Beitrag zu folgendem(n) Ziel(en) für nachhaltige Entwicklung

SDG 3 – Gesundheit und Wohlergehen

Dokumente

10.3109/10428194.2015.1099648

Weitere Links

Link to publication in Scopus

Zitieren

Gebauer, N., Biersack, H., Czerwinska, A. C., Schemme, J., Hardel, T. T., Bernard, V., Rades, D., Lehnert, H., Luley, K. B., & Thorns, C. (2016). Single nucleotide polymorphisms in TP53 but not KRAS or MDM2 are predictive of clinical outcome in multiple myeloma treated with high-dose melphalan and autologous stem cell support. Leukemia and Lymphoma, 57(6), 1482-1486. https://doi.org/10.3109/10428194.2015.1099648

@article{2841061113bf4f6fb1000e2ede77438b,

title = "Single nucleotide polymorphisms in TP53 but not KRAS or MDM2 are predictive of clinical outcome in multiple myeloma treated with high-dose melphalan and autologous stem cell support",

author = "Niklas Gebauer and Harald Biersack and Czerwinska, \{Ann Cathrin\} and Janina Schemme and Hardel, \{Tim Tristan\} and Veronica Bernard and Dirk Rades and Hendrik Lehnert and Luley, \{Kim Barbara\} and Christoph Thorns",

year = "2016",

month = jun,

day = "2",

doi = "10.3109/10428194.2015.1099648",

language = "English",

volume = "57",

pages = "1482--1486",

journal = "Leukemia and Lymphoma",

issn = "1042-8194",

publisher = "Taylor and Francis Ltd.",

number = "6",

}

Gebauer, N, Biersack, H, Czerwinska, AC, Schemme, J, Hardel, TT, Bernard, V, Rades, D, Lehnert, H, Luley, KB & Thorns, C 2016, 'Single nucleotide polymorphisms in TP53 but not KRAS or MDM2 are predictive of clinical outcome in multiple myeloma treated with high-dose melphalan and autologous stem cell support', Leukemia and Lymphoma, Jg. 57, Nr. 6, S. 1482-1486. https://doi.org/10.3109/10428194.2015.1099648

Single nucleotide polymorphisms in TP53 but not KRAS or MDM2 are predictive of clinical outcome in multiple myeloma treated with high-dose melphalan and autologous stem cell support. / Gebauer, Niklas; Biersack, Harald; Czerwinska, Ann Cathrin et al.
in: Leukemia and Lymphoma, Jahrgang 57, Nr. 6, 02.06.2016, S. 1482-1486.

Publikation: Beiträge in Fachzeitschriften › Briefe › Begutachtung

TY - JOUR

T1 - Single nucleotide polymorphisms in TP53 but not KRAS or MDM2 are predictive of clinical outcome in multiple myeloma treated with high-dose melphalan and autologous stem cell support

AU - Gebauer, Niklas

AU - Biersack, Harald

AU - Czerwinska, Ann Cathrin

AU - Schemme, Janina

AU - Hardel, Tim Tristan

AU - Bernard, Veronica

AU - Rades, Dirk

AU - Lehnert, Hendrik

AU - Luley, Kim Barbara

AU - Thorns, Christoph

PY - 2016/6/2

Y1 - 2016/6/2

UR - https://www.scopus.com/pages/publications/84946962392

U2 - 10.3109/10428194.2015.1099648

DO - 10.3109/10428194.2015.1099648

M3 - Letters

C2 - 26414189

AN - SCOPUS:84946962392

SN - 1042-8194

VL - 57

SP - 1482

EP - 1486

JO - Leukemia and Lymphoma

JF - Leukemia and Lymphoma

IS - 6

ER -